|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-2-28
|
|
pubmed:abstractText |
High-dose radiotherapy after surgical debulking is the treatment of choice for chordomas and chondrosarcomas. This study reviewed our outcomes, in relation to residual tumour volume and radiation dose, in order to inform our future practice.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1433-2981
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
199-208
|
|
pubmed:meshHeading |
pubmed-meshheading:20980136-Adolescent,
pubmed-meshheading:20980136-Adult,
pubmed-meshheading:20980136-Aged,
pubmed-meshheading:20980136-Aged, 80 and over,
pubmed-meshheading:20980136-Chondrosarcoma,
pubmed-meshheading:20980136-Chordoma,
pubmed-meshheading:20980136-Female,
pubmed-meshheading:20980136-Humans,
pubmed-meshheading:20980136-Kaplan-Meier Estimate,
pubmed-meshheading:20980136-Male,
pubmed-meshheading:20980136-Middle Aged,
pubmed-meshheading:20980136-Neoplasm, Residual,
pubmed-meshheading:20980136-Prognosis,
pubmed-meshheading:20980136-Radiotherapy,
pubmed-meshheading:20980136-Sensitivity and Specificity,
pubmed-meshheading:20980136-Skull Base Neoplasms,
pubmed-meshheading:20980136-Spinal Neoplasms,
pubmed-meshheading:20980136-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Residual postoperative tumour volume predicts outcome after high-dose radiotherapy for chordoma and chondrosarcoma of the skull base and spine.
|
|
pubmed:affiliation |
Oncology Centre (Box 193), Addenbrooke's Hospital, Hills Road, Cambridge, UK.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
